Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon
Tech Nation: My Creations Have Upgrade Panels
Chapter 182

Price Reveal, Netizens Spitting Blood

1,381 words 5 min read 2 views 2mo ago Source ​
Skip to the end of the chapter
Prev
Next

Now, as they oppose modifying their own genes, the 'EBT-002 gene therapy' has been divided into two versions.

The original 'EBT-002 gene therapy drug' has effectively increased in price by 10,000 yuan, doubling its cost. This means that if they want to obtain lifelong immunity to AIDS, they will need to pay twice as much.

Faced with this situation, how could those AIDS patients not be so angry that they would vomit blood?

At this moment, all they want to do is curse, find out who opposes modifying their own genes, and then beat them up.

As for why Xingtu Fund Company created two versions of the 'EBT-002 gene therapy drug'?

The reason is that the West developed its own AIDS drug, 'Bode-001 AIDS drug', and Xingtu Gene Company also produced two versions in response.

The goal is to overcome the impact of the 'Bode-001 AIDS drug', directly compete with them through differentiation, and maintain its own high profits.

From this point on, the 'EBT-002 gene therapy drug' and the 'Bode-001 AIDS drug', which do not modify the human gene version, will face fierce competition, and their prices will be similar in the future.

The lifelong immunity version, which provides lifelong immunity to AIDS virus, will be in a high-end position. Due to its higher price, even if fewer people are injected, the actual profit will be higher.

As for whether they object, those who object can simply purchase the unmodified version of 'EBT-002 Gene Therapy Agent'.

Of course, what AIDS patients are thinking is irrelevant to Lu Shouyi, a hepatitis B patient who is about to die.

When he heard that the 'Starway EBT-107 Hepatitis B Gene Therapy Agent' could completely eradicate many known types of Hepatitis B virus, he was so happy he almost jumped for joy.

Because this means that it can really cure that damn hepatitis B disease.

At this moment, he was extremely grateful to Lin Feng, for giving him a second life and Lin Feng saving his family.

However, one question remains unresolved: how much does the 'Starway EBT-107 Hepatitis B Gene Therapy Agent' actually cost?

After all, the savings of his family and both sets of parents had been emptied six months ago, and even though he worked hard for several months after giving up treatment.

However, even with spending money while saving, the savings accumulated over several months did not exceed 10,000 yuan.

If the price of 'Starway EBT-107 Hepatitis B Gene Therapy Agent' is too high at this time, it will undoubtedly shatter their family's hopes.

In the video, after introducing some other aspects of the 'Starway EBT-107 Hepatitis B Gene Therapy Agent', Lin Feng quickly moved on to the price disclosure segment.

"Alright, now let me announce the price of 'Starway EBT-107 Hepatitis B Gene Therapy Agent'."

As Lin Feng spoke, the video suddenly changed to a price introduction.

The price displayed on this price information screen is 12,000 yuan before medical insurance coverage.

Upon seeing this price, many people's lips twitched, completely unexpected that Xingtu Technology's potions would increase in price.

The price has jumped from an average of 10,000 yuan to 12,000 yuan, an increase of 2,000 yuan, which is quite a significant increase.

However, compared to another Hepatitis B Special Medicine, Sofosbuvir, Xingtu Technology's price is still quite affordable.

After all, another Hepatitis B Special Medicine Sofosbuvir, costs 21,660 yuan, a price that is simply unaffordable for ordinary families.

Moreover, the 21,660 yuan is only the price of one bottle of Sofosbuvir. In reality, it takes at least three months for YC to go from positive to negative.

This means that three bottles over three months would cost a total of 64,000 yuan, a price that many families simply cannot afford, as many families do not have that much savings.

Currently, a bottle of 'Xingtu EBT-107 Hepatitis B Gene Therapy Agent' only costs 12,000 yuan, which is quite affordable and acceptable.

Of course, their joy didn't last long, because this only represented the price of one bottle; nobody knew exactly how many bottles would be injected.

So they looked at the subsequent descriptions and found that 'Starway EBT-107 Hepatitis B Gene Therapy Agent' was the same as 'EBT-002 Gene Therapy Agent'.

They all need to inject at least two vials. Whether a third vial is needed depends on whether the Hepatitis B virus is still present in their bodies.

In response, hepatitis B patients on the internet have begun to calculate the price.

The price of the medicine was found to be between 24,000 and 36,000 yuan. After deducting medical insurance, only a fraction of the price would be paid, which was still within an acceptable range.

At least it's almost half the price of another Hepatitis B Special Medicine, Sofosbuvir.

Moreover, it guarantees that only two to three bottles are needed to clear the Hepatitis B virus, and that the treatment time is only a few days.

Overall, Xingtu Gene Company's 'Xingtu EBT-107 Hepatitis B Gene Therapy Agent' is superior to Gilead Company's Sofosbuvir in all aspects.

If people were given a choice, they would definitely prioritize using 'Starway EBT-107 Hepatitis B Gene Therapy Agent'.

After all, the 'Starway EBT-107 Hepatitis B Gene Therapy Agent' can guarantee 100% clearance of the Hepatitis B virus, while Sofosbuvir not make such a guarantee.

Finally, given that Sofosbuvir is so expensive and the treatment takes up to three months, hepatitis B patients will naturally vote with their feet and choose 'Xingtu EBT-107 Hepatitis B Gene Therapy Agent'.

As the prices were revealed, hepatitis B patients knew which option to choose.

On the other side, in the video, when the hepatitis B patient or their family was extremely emotional, Lin Feng continued:

"Our 'Starway EBT-107 Hepatitis B Gene Therapy Agent' is much safer because it does not modify human genes and only targets the Hepatitis B virus."

Therefore, the Medical Bureau of the Great Xia have expedited the approval of the clinical trial application, and the clinical trial will soon begin.

We expect our 'Starway EBT-107 Hepatitis B Gene Therapy Agent' to be launched in about one or two months.

So to all those around the world suffering from hepatitis B, please hold on for another month or two and don't give up hope of survival.

As for other countries, we have already submitted clinical trial application documents, hoping that the Medical Bureau in those countries can expedite the approval process and bring the products to market as soon as possible.

After all, 1.3 million people die from Hepatitis B virus every year worldwide, which means that on average, one person dies from Hepatitis B virus every 30 seconds.

Here, I sincerely hope that Medical Bureau in various countries overseas can expedite the approval process for clinical trial applications.

Don't let it be like the AIDS treatment 'EBT-002 gene therapy', where more than three months have passed.

As a result, clinical trials have not yet been approved, and the market launch date is still far off.

I have absolutely no idea why they refused to approve the clinical trial application, even if it was due to safety concerns.

In the past three months, a total of 9 million people worldwide have received the 'EBT-002 gene therapy agent' in Great Xia, and there have been no deaths among them. What is there for them to worry about?

If there are any side effects, three months should be enough time to show them. Aren't 9 million samples enough?

Regarding the issue that the efficacy of the 'RNP Complex' will gradually decrease over time after the transportation distance is too long.

We can easily choose a country near any of the major states to build a production plant, allowing nearby patients to obtain the 'EBT-002 gene therapy drug' through expedited air transport channels.

Therefore, the only factor is that the 'EBT-002 gene therapy drug' has been prevented from being launched overseas due to political or economic reasons!

Here, I sincerely hope that some people overseas can go to the hospital to see those patients suffering from illness and witness their pain and hardship.

Stop disregarding human life and ignoring the people's grief for a pittance.

End of Chapter
Prev
NovelSummaries
Next

Explore the wiki

Lin Feng
Xingtu Technology
Great Xia

Comments

No comments yet.
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS